Trial intelligence / Profile preview

Efficacy of haloperidol to decrease the burden of delirium in adult critically ill patients

2017-003115-20Phase 4Active

Sponsor
Erasmus MC
Start
Oct 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of haloperidol in delirium, sponsored by Erasmus MC. Started Oct 2017; status: active.

02

Drugs

haloperidol
03

Conditions

delirium

Beyond the preview

Go deeper on 2017-003115-20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-003115-20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call